Company: SCLXW
Filing Date: 2025-01-17
Form Type: 10-Q
Source: 0000950170-25-006755
Chunk: 42

Company: Scilex Holding Co
Filing Date: 2025-01-17
Form: 10-Q
Item: Item 1
Chunk 42
---

    179

    Total liabilities

    311,747

    274,247

    Commitments and contingencies (See Note 11)

    Stockholders’ deficit:

    Preferred stock, $0.0001 par value, 45,000,000 shares authorized; 29,057,097 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively

    —

    —

    Common stock, $0.0001 par value, 740,000,000 shares authorized; 191,790,520 shares issued and 131,721,935 shares outstanding as of September 30, 2024; 160,084,250 shares issued and 100,015,665 shares outstanding as of December 31, 2023

    19

    16

    Additional paid-in capital

    430,767

    407,813

    Accumulated other comprehensive income

    5,011

    —

    Accumulated deficit

    (556,592
    )

    (490,245
    )

    Treasury stock, at cost; 60,068,585 shares as of each of September 30, 2024 and December 31, 2023

    (90,522
    )

    (90,522
    )

    Total stockholders’ deficit

    (211,317
    )

    (172,938
    )

    Total liabilities and stockholders’ deficit
     
    $
    100,430

    $
    101,309

See accompanying notes to unaudited condensed consolidated financial statements

 1

SCILEX HOLDING COMPANY 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except for net loss per share amounts)

(Unaudited)

    Three Months Ended September 30,

    Nine Months Ended September 30,

    2024

    2023

    2024

    2023

    Net revenue
     
    $
    14,436

    $
    10,117

    $
    41,690

    $
    33,281

    Net operating costs and expenses:

    Cost of revenue

    3,768

    3,392

    11,998

    11,160

    Research and development